XYD190 (Compound 14g) is an orally active degrader for CBP/p300 . XYD190 inhibits CBP/p300 bromodomain with IC 50 of 483.7 nM. XYD190 exhibits antitumor activity against acute myeloid leukemia. (Pink: CBP/p300 ligand ( HY-161495 ); Blue: Cereblon ligand ( HY-41547 ); Black: linker ( HY-161496 )).
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > PROTAC | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > PROTACs | Products > Signaling Pathways > Epigenetic Reader Domain | Products > Signaling Pathways > Histone Acetyltransferase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.